Need professional-grade analysis? Visit stockanalysis.com
$38.92M
N/A
N/A
N/A
Talphera Inc. (TLPH) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.79, up 3.69% from the previous close.
Over the past year, TLPH has traded between a low of $0.39 and a high of $1.46. The stock has gained 60.4% over this period. It is currently 46.2% below its 52-week high.
Talphera Inc. has a market capitalization of $38.92M.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Side-by-side comparison against top Healthcare peers.